JamesCGrottaMD

Neurology • Houston, TX

Vascular Neurology

Direct Mobile Stroke Unit Vascular Neurologist Memorial Hermann Hospital

Join to view full profile

Dr. Grotta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grotta's full profile

Already have an account?

Office
6410 Fannin St
Ste 1014
Houston, TX 77030
Phone+1 832-325-7080

Fax+1 713-512-2239

Education & Training

Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1978 - 1979
University of ColoradoResidency, Neurology, 1974 - 1977
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1971 - 1972
University of Virginia School of MedicineClass of 1971

Certifications & Licensure

TX State Medical License 1979 - 2025
LA State Medical License 2010 - 2017
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:SE Texas Castle Connolly, 2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Caffeinol Hypothermia Protocol Start of enrollment: 2003 Feb 01
Completed
Phase 1, Phase 2
The Intravascular Cooling in the Treatment of Stroke 2/3 Trial Start of enrollment: 2010 Jun 01
Terminated
Phase 2, Phase 3
CLOTBUST Hands-Free: A Phase I/II Pilot Safety Trial Start of enrollment: 2008 Dec 01
Completed
Phase 1, Phase 2
Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke Start of enrollment: 2011 Oct 01
Terminated
Phase 2
BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Start of enrollment: 2014 Aug 01
Active, not recruiting
Phase 2, Phase 3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Start of enrollment: 2021 Dec 03
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Critical Care Decisions After Large Core Cerebral Infarctions: A Secondary Analysis From the SELECT2 Trial.
Scott E Kasner, Michael T Mullen, Michael DeGeorgia, Spiros Blackburn, Donna K George
Annals of Neurology. 2024-12-09
A Prospective Multicenter Analysis of Mobile Stroke Unit Cost-Effectiveness.
Suja S Rajan, Jose-Miguel Yamal, Mengxi Wang, Jeffrey L Saver, Asha P Jacob
Annals of Neurology. 2024-12-03
1 citations
Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis.
Brian Mac Grory, Jie-Lena Sun, Brooke Alhanti, Jay Lusk, Fan Li
JAMA Neurology. 2024-12-01

Authored Content

Antiplatelet Therapy After Ischemic Stroke or TIAMay 2018

Press Mentions

Memorial Hermann Houston Mobile Stroke Unit EarnsDecember 6th, 2024
Mobile Stroke Units: The Barriers to Timely tPA Administration in the USMarch 31st, 2023
El Campo Stroke Patient Feeling '100 Percent' Following Mom's Call to Get Her in a Clinical TrialFebruary 15th, 2023
Join now to see all

Grant Support

Clotbust-Hf Combined Lysis Of Thrombus In Brain Ischemia With Transcranial UltrasNational Institute Of Neurological Disorders And Stroke2008–2011
Clinical CoreNational Institute Of Neurological Disorders And Stroke2008–2011
University Of Texas Specialized Program In Acute StrokeNational Institute Of Neurological Disorders And Stroke2003–2011
The University Of Texas Houston Stroke Training ProgramNational Institute Of Neurological Disorders And Stroke1998–2011
Ictus 2/3National Institute Of Neurological Disorders And Stroke2010
A Pilot Study To Determine The Safety Of Argatroban Injection In Combination WithNational Institute Of Neurological Disorders And Stroke2009
26th Princeton Conference On Cerebrovascular DiseaseNational Institute Of Neurological Disorders And Stroke2008
Calcium Blocker And Related Therapy For Stroke RecoveryNational Institute Of Neurological Disorders And Stroke1999–2004
Treatment Of Acute Stroke Ethanol And CaffeineNational Institute Of Neurological Disorders And Stroke2002
Specialized Program In Acute StrokeNational Institute Of Neurological Disorders And Stroke2002
Core--TrainingNational Institute Of Neurological Disorders And Stroke2002
Core--ClinicalNational Institute Of Neurological Disorders And Stroke2002
Constraint Induced Movement Therapy In Subacute StrokeNational Institute Of Neurological Disorders And Stroke2002
Argatroban In Combination With Rt-Pa In Ischemic StrokeNational Institute Of Neurological Disorders And Stroke2002
Calcium Blocker And Related Therapy For StrokeNational Institute Of Neurological Disorders And Stroke1995–1998
Calcium Blocker &Related Therapy For Cerebral IschemiaNational Institute Of Neurological Disorders And Stroke1987–1993
Study Calcium Antagonists In Treating Acute StrokeNational Institute Of Neurological Disorders And Stroke1985–1988